熱門資訊> 正文
守夜神经科学GAAP每股收益为-0.52美元
2024-08-13 20:35
- Vigil Neuroscience press release (NASDAQ:VIGL): Q2 GAAP EPS of -$0.52.
- Cash, cash equivalents, and marketable securities were $86.7 million as of June 30, 2024, compared to $101.6 million as of March 31, 2024.
-
More on Vigil Neuroscience
- Vigil Neuroscience reports interim data from its once-daily oral therapy for Alzheimer’s
- Biggest stock movers today: WBA, BB, MU, and more
- Seeking Alpha’s Quant Rating on Vigil Neuroscience
- Historical earnings data for Vigil Neuroscience
- Financial information for Vigil Neuroscience
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。